C12N 2760/12251
Methods of production or purification of viral material
C12N2760/12251 (Methods of production or purification of viral material) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 7
- Inventors
- 19
- Latest grant
- 9 May 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Rift valley fever vaccine9 May 2023US 11,643,640 B2Board of Regents, The University of Texas System
- Rift valley fever virus replicon particles and use thereof27 Jun 2017US 9,687,542 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
- Pathogenic phlebovirus isolates and compositions and methods of use23 Aug 2016US 9,421,250 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Modified filamentous fungi for production of exogenous proteins5 Oct 2023US 2023/0313121 A1Dyadic International (USA), Inc.
- Rift valley fever vaccine15 Apr 2021US 2021/0108181 A1Board of Regents, The University of Texas System
- Lone star virus24 Mar 2016US 2016/0083698 A1The Regents of the University of California
- Rift valley fever virus replicon particles and use thereof16 Jul 2015US 2015/0196630 A1The Government of the United States of America as represented by the Secretary of the Department of
- Pathogenic phlebovirus isolates and compositions and methods of use26 Mar 2015US 2015/0086577 A1The Government of the United States of America as represented by the Secretary of the Department of
Most cited
By later US patents
- Pathogenic phlebovirus isolates and compositions and methods of use1US 9,421,250 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016
- Rift valley fever virus replicon particles and use thereof1US 9,687,542 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services · 2017